Candida albicans mutants deficient in respiration are resistant to the small cationic salivary antimicrobial peptide histatin 5.
about
Candidacidal activities of human lactoferrin peptides derived from the N terminusThe antimicrobial peptide histatin-5 causes a spatially restricted disruption on the Candida albicans surface, allowing rapid entry of the peptide into the cytoplasmEffects of histatin 5 and derived peptides on Candida albicansMUC7 20-Mer: investigation of antimicrobial activity, secondary structure, and possible mechanism of antifungal actionInternalisation and degradation of histatin 5 by Candida albicans.Human antimicrobial peptides and proteinsInhibition of electron transport chain assembly and function promotes photodynamic killing of Candida.The human salivary peptide histatin 5 exerts its antifungal activity through the formation of reactive oxygen species.Salivary histatin 5 and human neutrophil defensin 1 kill Candida albicans via shared pathways.Role of ATP-binding-cassette transporter genes in high-frequency acquisition of resistance to azole antifungals in Candida glabrata.Released ATP is an extracellular cytotoxic mediator in salivary histatin 5-induced killing of Candida albicans.Salivary histatin 5 internalization by translocation, but not endocytosis, is required for fungicidal activity in Candida albicans.Roles of cellular respiration, CgCDR1, and CgCDR2 in Candida glabrata resistance to histatin 5.Antimicrobial peptides: therapeutic potential for the treatment of Candida infections.Staphylococcus aureus susceptibility to innate antimicrobial peptides, beta-defensins and CAP18, expressed by human keratinocytesNanoscale adhesion forces between enamel pellicle proteins and hydroxyapatiteHistatins: antimicrobial peptides with therapeutic potential.Differentially expressed proteins in derivatives of Candida albicans displaying a stable histatin 3-resistant phenotypeThe P-113 fragment of histatin 5 requires a specific peptide sequence for intracellular translocation in Candida albicans, which is independent of cell wall binding.On the physiology and pathophysiology of antimicrobial peptides.How does it kill?: understanding the candidacidal mechanism of salivary histatin 5.The TRK1 potassium transporter is the critical effector for killing of Candida albicans by the cationic protein, Histatin 5.Endocytosis-mediated vacuolar accumulation of the human ApoE apolipoprotein-derived ApoEdpL-W antimicrobial peptide contributes to its antifungal activity in Candida albicans.Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5.Internal thiols and reactive oxygen species in candidacidal activity exerted by an N-terminal peptide of human lactoferrin.Relationships between respiration and susceptibility to azole antifungals in Candida glabrata.The role of released ATP in killing Candida albicans and other extracellular microbial pathogens by cationic peptides.Candida albicans Impairments Induced by Peppermint and Clove Oils at Sub-Inhibitory Concentrations.T-2307 causes collapse of mitochondrial membrane potential in yeast.Antifungal Mechanism of Action of Lactoferrin: Identification of H+-ATPase (P3A-Type) as a New Apoptotic-Cell Membrane Receptor.Disruption of mitochondrial function in Candida albicans leads to reduced cellular ergosterol levels and elevated growth in the presence of amphotericin B.The Plant Defensin NaD1 Enters the Cytoplasm of Candida Albicans via Endocytosis.Deletion of the Candida albicans PIR32 results in increased virulence, stress response, and upregulation of cell wall chitin deposition.
P2860
Q24290527-5F562A83-0600-4C9D-BDA5-A9E5F9669867Q27318386-4A412907-94E1-440A-BD21-0685E82FA0A7Q28365530-DFFA2B70-026A-41A9-AD19-455E149855E0Q29871517-158D282F-D46D-46D2-9DC4-62CA75D0B75CQ30911101-C3DD59A4-7B51-4EB9-B19B-79F39A44FAA7Q33673156-474EF210-070A-4596-B34D-216BE7C66826Q33895907-14C963C8-ACFD-46E2-987F-7CA1826D51F1Q33952105-6DDA14E7-00BB-4595-9FBB-6C53F796572EQ33980976-AF5BB467-14D6-4989-9A89-2E59F0A83270Q33981896-AB704C28-AC6E-4B91-BCC5-7BF3DB49FD60Q34005242-A7B8D8D2-12D2-480A-AE5C-62F93C220E78Q34017572-7AC03401-26E9-4D93-97F9-9EEB2A4D6834Q34509765-1F76F320-44F5-4834-A52D-5F843CC79271Q34519189-B98F978F-F3C5-4A27-8859-4F3D378231CCQ35106151-429C67C3-1AB4-4943-A620-00065EE57CC9Q35109895-D09B00A7-8AD5-4260-912B-CC0CAE878D3BQ35693395-4FB708BB-F6F3-43BA-BA72-136346ADBE0AQ35912775-89D702C6-1891-42D1-A6D7-14A2D3852089Q36424968-D1EF9B8E-29E5-4995-B5DE-2CDE0E4C66D2Q37327972-B3975F0A-005E-4687-871D-B0864AF35B88Q38222086-271213F6-78E6-4E1F-A459-F4832D845767Q38335411-5487F0AC-0F5B-4513-8606-55710BF9B384Q38626954-F4793EB7-D84E-4B1A-BF2E-C91F8208C30AQ39477082-49D6B607-3B3D-488D-B286-2C7B860DA63CQ39651994-A1A266C3-13F4-4C1B-9298-51BC3F5CA037Q39731901-A160EFD9-40E0-4B4E-B829-DAA340F861E3Q40730220-5236CF67-561F-4C83-896B-899C8FBFB7EAQ41033509-7BEA5820-D23C-47A8-96A0-E7D47EA67328Q41571211-9E2F4A61-37B8-417F-899F-57AE395B653FQ41962388-B270EDEA-D89E-407B-8FA5-AAF60CE5DEF1Q44364431-C3A80A3B-3A84-4B63-9FA2-2C6635EDB80DQ50131973-51892648-4A18-4042-96D8-09C868B6A675Q53793280-6A7EA343-8382-473F-87EA-575B8343A2EA
P2860
Candida albicans mutants deficient in respiration are resistant to the small cationic salivary antimicrobial peptide histatin 5.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Candida albicans mutants defic ...... imicrobial peptide histatin 5.
@en
Candida albicans mutants defic ...... imicrobial peptide histatin 5.
@nl
type
label
Candida albicans mutants defic ...... imicrobial peptide histatin 5.
@en
Candida albicans mutants defic ...... imicrobial peptide histatin 5.
@nl
prefLabel
Candida albicans mutants defic ...... imicrobial peptide histatin 5.
@en
Candida albicans mutants defic ...... imicrobial peptide histatin 5.
@nl
P2093
P2860
P1476
Candida albicans mutants defic ...... imicrobial peptide histatin 5.
@en
P2093
F G Oppenheim
R F Troxler
U Lendenmann
P2860
P304
P356
10.1128/AAC.44.2.348-354.2000
P407
P577
2000-02-01T00:00:00Z